Merck KGaA : CMD feedback – strong resilient growth
>BIG3 to drive growth on group level - The capital market day emphasised the company’s exposure to attractively growing end markets as well as the resilient company structure. Merck KGaA expects more than 6% organic growth in the medium term and revenues of around € 25bn (ODDO BHF € 25.8bn) in 2025. BIG3 are seen contributing around 80% of growth and should have a share of sales of more than 50% in 2025. The medium-term guidance excludes external growth. Capex will in...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.